Search

Your search keyword '"Kanda, Yoshinobu"' showing total 615 results

Search Constraints

Start Over You searched for: Author "Kanda, Yoshinobu" Remove constraint Author: "Kanda, Yoshinobu" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
615 results on '"Kanda, Yoshinobu"'

Search Results

1. Association between human herpesvirus-6 encephalitis and antiviral prophylaxis after allogeneic hematopoietic stem cell transplantation in the letermovir era

2. Survival impact of response within the first year in a multicenter prospective observational study of chronic GVHD in a Japanese cohort

3. Updated comparable efficacy of cord blood transplantation for chronic myelomonocytic leukaemia: a nationwide study

5. Significance of absolute neutrophil count before allogeneic hematopoietic stem cell transplantation in adult patients with aplastic anemia

6. Impact of antithymocyte globulin usage and risk stratification for posttransplant lymphoproliferative disorders in aplastic anemia patients after allogeneic hematopoietic cell transplantation

7. Analysis of risk factors for fatal renal complications after allogeneic hematopoietic cell transplantation

8. Allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia not in remission

9. HLA haploidentical stem cell transplantation from HLA homozygous donors to HLA heterozygous donors may have lower survival rates than haploidentical transplantation from HLA heterozygous donors to HLA heterozygous donors: a retrospective nationwide analysis

10. Outcomes of allogeneic hematopoietic cell transplantation under letermovir prophylaxis for cytomegalovirus infection

11. Comparison of MEAM, MCEC and LEED high-dose chemotherapy followed by autologous stem cell transplantation in relapsed/refractory diffuse large B-cell lymphoma: data from the Japan Society for Hematopoietic and Cellular Therapy Registry

12. Superiority of BM over PBSC for recipients with pre-transplant lung dysfunction in HLA-matched allogeneic HCT

13. Allogeneic stem cell transplant with TBI-based myeloablative conditioning in adolescents and young adults with Philadelphia chromosome-negative ALL treated with pediatric protocols

14. External validation and extended application of the transplant conditioning intensity score in acute myeloid leukemia

15. Substitution of calcineurin inhibitors with corticosteroids after allogeneic hematopoietic cell transplantation

18. Risk factors and outcome of Stenotrophomonas maltophilia infection after allogeneic hematopoietic stem cell transplantation: JSTCT, Transplant Complications Working Group

19. Associations between acute and chronic graft-versus-host disease

20. Author Correction: A convolutional neural network-based model that predicts acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

22. A convolutional neural network-based model that predicts acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

23. Impact of HLA disparity on overall mortality risk in patients with extensive chronic GVHD: The HLA Working Group of Japanese Society for Transplantation and Cellular Therapy

25. Different effects of thymoglobulin on acute leukemia with pre-transplant residual blasts in HLA mismatch transplantation

26. Differential clinical impact of letermovir prophylaxis according to graft sources: a KSGCT multicenter retrospective analysis

27. Potential role of HTLV-1 Tax-specific cytotoxic t lymphocytes expressing a unique t-cell receptor to promote inflammation of the central nervous system in myelopathy associated with HTLV-1.

28. Impact of stem cell selection between bone marrow and peripheral blood stem cells for unrelated hematopoietic stem cell transplantation for hematologic malignancies: on behalf of the Donor/Source Working Group of the Japanese Society for Transplantation and Cellular Therapy

29. Female-to-male allogeneic transplantation affects outcomes differently according to the type of haplo-transplantation

30. Superior Survival After Unrelated Allogeneic Stem Cell Transplantation With Low-Dose ATG Compared to Low-Dose TBI in Myeloablative Fludarabine/Busulfan-Based Regimen for MDS on Behalf of the Adult MDS Working Group of the JSTCT

31. Clinical impact of a change in antibiotics or the addition of glycopeptide antibiotics for persistent febrile neutropenia after autologous stem cell transplantation

34. Impact of standard-dose dipeptidyl peptidase-4 inhibitors on the incidence of graft-versus-host disease after allogeneic hematopoietic cell transplantation

35. Effect of the COVID-19 pandemic on allogeneic stem cell transplantation in Japan

39. Clinical significance of late CMV disease in adult patients who underwent allogeneic stem cell transplant

40. Adverse impact of delay of platelet recovery after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma and multiple myeloma

41. Outcomes in human T-cell leukemia virus type I carriers after hematopoietic stem cell transplantation for diseases other than adult T cell leukemia/lymphoma: a Japanese national survey

42. Treatment strategy at the decision for allogeneic transplantation in patients with myelodysplastic syndrome in the era of azacitidine: A KSGCT prospective study

43. Antibody-mediated pathogenesis of chronic GVHD through DBY/HLA class II complexes and induction of a GVL effect

45. Identifying the optimal conditioning intensity for stem cell transplantation in patients with myelodysplastic syndrome: a machine learning analysis

49. Dose-finding trial of azacitidine as post-transplant maintenance for high-risk MDS: a KSGCT prospective study

50. The hepatic niche leads to aggressive natural killer cell leukemia proliferation through the transferrin–transferrin receptor 1 axis

Catalog

Books, media, physical & digital resources